News stories about Stryker Corporation (NYSE:SYK) have trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stryker Corporation earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the medical technology company an impact score of 46.326683847508 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s analysis:
- Nano Healthcare Technology for Medical Equipment Market to Reach US$ 9.2 Bn by 2022 – Persistence Market Research (prnewswire.com)
- Research Report and Overview on Therapeutic Beds Market, 2015-2021 (reports.pr-inside.com)
- Craniomaxillofacial Implants Market Surge Towards Solid Growth by 2024 (sbwire.com)
- Global Surgical Robotics Market Expected to Reach Worth US$ 12.62 Bn by 2025 – Credence Research (abnewswire.com)
- Stryker Corporation (SYK) Stake Decreased by Hall Laurie J Trustee – First News 24 (firstnewspaper24.com)
A number of research firms recently commented on SYK. Cowen and Company set a $160.00 price objective on Stryker Corporation and gave the stock a “buy” rating in a research note on Friday, October 6th. Zacks Investment Research lowered Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, August 17th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Royal Bank Of Canada lifted their price objective on Stryker Corporation from $140.00 to $155.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 price objective on Stryker Corporation and gave the stock a “hold” rating in a research note on Friday, July 28th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $146.78.
Shares of Stryker Corporation (SYK) opened at 144.69 on Wednesday. Stryker Corporation has a one year low of $106.48 and a one year high of $149.23. The company has a market cap of $54.12 billion, a P/E ratio of 32.30 and a beta of 0.81. The company’s 50-day moving average price is $142.48 and its 200 day moving average price is $140.29.
Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.39 EPS. On average, equities research analysts anticipate that Stryker Corporation will post $6.45 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.
In related news, insider Graham A. Mclean sold 1,124 shares of Stryker Corporation stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of Stryker Corporation stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Receives News Sentiment Rating of 0.15” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://ledgergazette.com/2017/10/11/stryker-corporation-syk-receives-news-sentiment-rating-of-0-15.html.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.